This grant, provided by the National Institutes of Health (NIH), is dedicated to advancing transformative technologies that significantly enhance the precise and efficient delivery of pharmacological, gene editing, and other crucial cargoes. Its fundamental purpose is to spur the development of innovative methods for transporting therapeutic and research agents directly to target cells or tissues, thereby overcoming existing delivery barriers. The primary scope of this funding opportunity centers on supporting both mechanistic and therapeutic research for Human Immunodeficiency Virus (HIV) and Substance Use Disorders (SUDs). Successful proposals will contribute to developing more effective treatment strategies and gaining deeper biological insights by revolutionizing how these essential substances are administered. This initiative is crucial for accelerating breakthroughs in managing and understanding these public health challenges.
Opportunity ID: 331751
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-22-010 |
| Funding Opportunity Title: | Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 26, 2021 |
| Last Updated Date: | Feb 26, 2021 |
| Original Closing Date for Applications: | Oct 25, 2022 |
| Current Closing Date for Applications: | Oct 25, 2022 |
| Archive Date: | Nov 30, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) State governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Independent school districts Private institutions of higher education City or township governments For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity is to develop technologies to improve the delivery of pharmacological, gene editing, or other cargoes for HIV and SUD mechanistic research. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-010.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 331751 Full Announcement-RFA-DA-22-010 -> RFA-DA-22-010-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00265688 | Sep 25, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269858 | Oct 28, 2021 | Oct 25, 2022 | View |
Package 1
Mandatory forms
331751 RR_SF424_2_0-2.0.pdf
331751 PHS398_CoverPageSupplement_5_0-5.0.pdf
331751 RR_OtherProjectInfo_1_4-1.4.pdf
331751 PerformanceSite_2_0-2.0.pdf
331751 RR_KeyPersonExpanded_2_0-2.0.pdf
331751 PHS398_ResearchPlan_4_0-4.0.pdf
331751 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
331751 RR_Budget_1_4-1.4.pdf
331751 RR_SubawardBudget30_1_4-1.4.pdf
331751 PHS398_ModularBudget_1_2-1.2.pdf
331751 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
331751 RR_SF424_5_0-5.0.pdf
331751 PHS398_CoverPageSupplement_5_0-5.0.pdf
331751 RR_OtherProjectInfo_1_4-1.4.pdf
331751 PerformanceSite_4_0-4.0.pdf
331751 RR_KeyPersonExpanded_4_0-4.0.pdf
331751 PHS398_ResearchPlan_4_0-4.0.pdf
331751 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
331751 RR_Budget_3_0-3.0.pdf
331751 RR_SubawardBudget30_3_0-3.0.pdf
331751 PHS398_ModularBudget_1_2-1.2.pdf
331751 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
